arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MILESTONE SCIENTIFIC INC.

MLSS
$0.41 ▲ +0.01 (+1.46%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
67 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
10
Health
Poor
Bearish
auto_awesome

Analytical Summary

MILESTONE SCIENTIFIC INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $38.2M
Dividend Yield
Revenue Growth 22.3%
Op. Margin -37.4%
ROIC -24.2%
FCF / Share $-0.01
Trailing P/E
Price / Book 10.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.84M
↑ +22.3%
Net Income Profit after all expenses
$-839.85K
↑ +57.9%
Operating Margin Operating profit as % of sales
-37.4%
↑ +2.4% 4th
FCF / Share Free cash flow per share
$-0.01
↓ -731.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
2
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters